所有實體腫瘤

Cancer Type

腫瘤組織(FFPE)

Specimen Requirements

2-4 個工作天

Turnaround Time ¹

ACT Nonet™ 是一款特製的 RT-PCR 腫瘤組織檢測。它涵蓋了 11 個基因的 167 個變異,這些變異有美國 FDA 批准的靶向治療。包括所有 NCCN 指引建議的基因和具有高靈敏度的特性(1~5% of DNA, 125 copies/reaction for RNA)。

RT-PCR Customizable Tissue Panel

167

Variants

11

Specially Curated Genes

≥99.9%

Clinical sensitivity & specificity

Hallmarks of ACT Nonet™

優化

省時、省成本、節省組織切片

創新

包含 NCCN 指南推薦的基因

廣泛

涵蓋具有美國 FDA 核准的靶向治療的基因

Summary

•Thetest can detect the presence of 167 hotspot genetic alterations
•Limit of detection: 1-5% DNA mutation; 300 copies for RNA fusion
•Analytical sensitivity: >99.9%; Analytical specificity: >99.9%

Technical Specifications

RT-PCR

167 variants of 11 genes

Specimen Requirements2

Tumor tissue (FFPE)

Target Genes

ALK, ROS1, RET1, NTRK1/2/3, MET, EGFR, BRAF, KRAS, HER2

Documentation

Brochure
Download

Disclaimers / Footnotes

  1. Turnaround time starts from the date of receipt of approved samples at our CAP-accredited laboratory.
  2. Please refer to our specimen instructions.

Book a Test

Explore the immense possibilities and promising future of precision medicine. Together, let us unlock the power of genomic testing and personalize cancer care for the most effective treatment.

Get Started